Anticholinesterase Flashcards
Neostigmine Class
Anticholinesterase or Cholinesterase Inhibitor
Neostigmine Uses
Reversal of non-depolarizing neuromuscular blockade
Produce parasympathetic effect to treat paralytic ileus and atonic bladder
Treat myasthenia gravis (neostigmine, pyridostigmine)
Postoperative analgesia (neostigmine, intrathecal or epidural)
Neostigmine MOA
Inhibits destruction of Ach by acetylcholinesterase which facilitates transmission of impulses across the NMJ
Excess Ach displaces NMBAs adn
Produces direct muscarinic activation via increased Ach levels (parasympathetic effects)
Neostigmine Dosing
25 – 50 mcg/kg, 5 mg maximum
Based on monitoring and clinical condition
2-3 TOF twitches 50 mcg/kg
4 TOF twitches with fade 40 mcg/kg
4 TOF twitches without fade 15-25 mcg/kg
Neostigmine Onset and DOA
Onset: 15 minutes
DOA: 45 minutes
Neostigmine Metabolism
Psuedocholinesterases (50%)
Neostigmine Excretion
Eliminated by the kidneys (50% unchanged)
Neostigmine Effects on Body (5)
Miosis Bradycardia Salivation Bronchoconstriction Peristalsis
Neostigmine Administration Considerations
Administered with an antimuscarinic (eg glycopyrrolate)
Ex: I mg of neostigmine with 0.2 mg of glycopyrrolate